Skip to main content

New Categories of Water Treatment Chemicals Added to NSF/ANSI/CAN 60

Updates to NSF/ANSI/CAN 60 now allow testing and certification for acetic acid, citric acid, BCDMH and chlorine dioxide used in municipal drinking water treatment.

The most recent additions to NSF/ANSI/CAN 60: Drinking Water Treatment Chemicals - Health Effects were issued in December 2020. The following new categories were added to the standard:

Acetic acid was added for biological substrate end use. When used as a biological substrate, acetic acid is added to the water treatment process to serve as an electron donor for reduction reactions in biological treatment systems.

Citric acid was added for use as a copper chelating agent, and as a separation process cleaner for use in reverse osmosis and distillation units to reduce built-up scale.

Bromochlorodimethylhydantoin (BCDMH) and chlorine dioxide were added as disinfection and oxidation products. These chemicals are used as disinfectants in the treatment of drinking water.

In addition to liquid chlorine dioxide solutions, NSF also certifies two-component kits used for on-site chlorine dioxide production at the end user (water utility) site under the category of Chlorine Dioxide Ingredients.

Have a question? Email Blake Stark.

NSF/ANSI/CAN 60

If you manufacture, sell or distribute water treatment chemicals for North America, your products are required to comply with NSF/ANSI/CAN 60: Drinking Water Treatment Chemicals - Health Effects.

Learn more

How NSF Can Help You

Get in touch to find out how we can help you and your business thrive.

What’s New with NSF

  • Spritzer Becomes First Malaysian Bottled Water Brand Certified by NSF for Beverage Quality

    May 21, 2026
    The leading Malaysian bottled water and beverages brand has earned NSF certification from ANSI-Accredited Product Certification Body – Accreditation #0216.
    Read the Story
  • NSF Annual Review and Impact Report 2025 Now Live

    April 20, 2026
    NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
    Read the Story
  • Visit NSF at Making Pharma 2026

    April 10, 2026
    Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.
    Read the Story